Rigetti Computing, Inc. Warrants news

Early-stage quantum computing company with minimal revenue ($7.1M, down 34% YoY), significant operating losses ($216M), but backed by major partners (Amazon, Microsoft, NASA, DOE) and recently awarded up to $100M in federal funding. Highly speculative with extremely high P/S ratio (409x) and uncertain commercialization timeline.

Insiders sold $75.7 million with zero insider buying activity. The company has an extreme 391.2 P/S ratio, suggesting severe overvaluation and insider skepticism about future prospects.

Despite impressive historical returns, the analyst explicitly recommends against investing due to extreme volatility, lack of profitability, substantial cash burn ($32M in H1 2026), minimal revenue ($5.1M Q2), and excessive valuation multiple (375x sales). The company remains in early stages with uncertain path to profitability, making it a high-risk investment unsuitable for conservative portfolios.

Rigetti shows promise with significantly faster quantum gate operations (60 nanoseconds) and demonstrated scalability to 108 qubits using chiplet architecture. However, accuracy degrades as systems scale (99.8% on 9-qubit to 99.1% on 108-qubit), and the company must achieve ambitious milestones within three years to close the gap with IonQ.

Company received $100 million in government funding to advance quantum computing research, demonstrating sector validation and providing capital for R&D. Stock price increased significantly (up to 12.2%). However, sentiment is tempered by minimal revenue generation and speculative nature of the business.

The company secured substantial $100M government funding to advance its quantum computing roadmap, demonstrating validation of its technology and strategic importance. This funding accelerates R&D toward utility-scale quantum computing and strengthens its competitive position. However, the equity stake given to the Department represents dilution to existing shareholders, which is a minor offsetting negative factor.

While the CFO's sale at a 52-week low could appear negative, the article emphasizes this was a non-discretionary, pre-planned transaction executed through a Rule 10b5-1 plan, not a reflection of insider pessimism. The CFO's substantial retained equity position (424,317 total shares/options) indicates continued alignment with shareholders. The neutral sentiment reflects that this is a routine insider transaction rather than a signal of fundamental company concerns.

Despite bullish Wall Street analyst recommendations (ABR 1.85, 8 Strong Buy ratings), Rigetti Computing received a Zacks Rank #5 (Strong Sell) rating. The consensus earnings estimate declined 24.4% over the past month to -$0.19, indicating growing analyst pessimism about the company's earnings prospects and suggesting the stock could plunge in the near term.

Part of the collective insider selling trend with virtually no insider buying. Trades at an extreme P/S ratio of 398, indicating severe overvaluation and lack of insider confidence in future appreciation.

The insider sale is non-discretionary and driven by tax obligations, not a loss of confidence. However, the company faces challenges with significant net losses (-$238.7M TTM) despite growing revenue. The Nvidia partnership and emerging quantum market position it positively, but high volatility (beta >2) and early-stage revenue generation warrant a neutral stance.

Rigetti faces significant challenges including 34.3% revenue decline in FY 2025, massive net losses (negative 3,050% margin), negative free cash flow of $77.2 million, heavy dependence on government contracts (90% of revenue), and no guarantee of achieving quantum advantage before competitors.

Noted for superconducting hardware development and government funding potential, but described as a narrow bet with technology and capital markets risk dependent on quantum adoption timeline.

Stock gained 7.7% on positive sector momentum from competitor's AT&T deal, plus new buy rating from Benchmark analyst with $25 price target implying 67% upside. However, sentiment is tempered by acknowledgment that profitability remains 5+ years away.

The article presents a balanced view with three scenarios. While the company has strong cash reserves ($569 million) and government validation, it faces significant challenges: massive R&D spending ($19.9M) against minimal revenue ($4.4M), high execution risk on milestones, and inevitable share dilution. The base case suggests continued survival but no near-term profitability, making it a speculative investment dependent on future technical breakthroughs rather than current fundamentals.

While Rigetti has strong fundamentals (full-stack vertical integration, $569M cash, no debt) and significant growth potential in quantum computing, it currently has minimal revenue, operates at a loss, and exhibits extreme volatility. The stock is down 33% YTD despite positive developments, making it a high-risk speculative play suitable only for risk-tolerant investors with small positions.

Offers faster speeds with superconducting qubits but significantly lags in accuracy at 99.1%, which is described as 'way behind' competitors despite sounding close numerically.

Part of the insider selling trend with $988M sold collectively. Despite 1,200% gains, insiders are not buying, indicating skepticism about valuations and future growth despite current hype.

The article frames Rigetti as a 'huge winner' with strategic advantages including domestic manufacturing capability, government support, and a superconducting quantum platform. The company received $100 million from the Trump Administration, positioning it favorably if quantum technology becomes treated as critical infrastructure. However, the 'risky' characterization and recent stock decline (-7.54%) temper the optimism.

Zero insider purchases over two years despite significant insider selling activity. Extreme negative gross margin (-5945.49%) and overvalued price-to-sales ratio indicate fundamental concerns about the business model and profitability timeline.

Stock experienced a 9.2% intraday crash with no specific negative catalyst, indicating investor uncertainty. Despite government support, analysts project the company won't be profitable until 2031 or later, creating significant long-term risk. The volatility and gap between near-term hype and distant profitability timelines suggest caution for investors.

While the $100 million federal funding is positive and signals government confidence in the company's quantum technology, the article emphasizes that this alone does not justify a buy recommendation. The company's extremely high valuation (P/S of ~700), minimal revenue ($10 million), significant operating losses, and pre-commercial stage indicate the funding does not offset fundamental financial concerns. The sentiment is neutral rather than negative because the funding does provide strategic value and potential acceleration of progress.

Uses superconducting approach with 99.1% 2-qubit gate fidelity (below commercial viability threshold), significantly lower revenue ($4.4M in Q1), and substantially smaller market presence. While not dismissed entirely, positioned as lagging behind IonQ with potential for future breakthroughs.

Company shows promising fundamentals with government backing, revenue growth, and strong cash position, but remains unprofitable with highly speculative long-term prospects dependent on unproven quantum computing commercial applications. High volatility and competitive threats warrant cautious outlook.

Received $100M in federal funding but faces same fundamental issues as peers: high P/S ratio (32.26), negative EBITDA, minimal revenue, and extreme vulnerability to market corrections. Author explicitly recommends against buying at these levels.

Company faces significant accuracy challenges with its superconducting approach (99.1% vs 99.5% target), delayed product releases, and failed to advance in DARPA's Quantum Benchmarking Initiative. Despite $100M government funding, these technical setbacks indicate the technology lags competitors.

Stock gained 9.63% on the day and surged over 60% in the past week following $2 billion in U.S. government quantum funding announcement. Company is positioned as a leader in superconducting quantum processors with long-term growth potential.

Insiders have been decisive net sellers with only $625,000 in buying over five years. Extremely high P/S ratio of 836 suggests overvaluation. Insider actions signal lack of confidence in future appreciation.

Company announced $100 million government investment over three years to accelerate quantum technology development, recognized by analysts as a major beneficiary of U.S. quantum computing initiatives, driving significant stock price gains.

While the stock experienced a dramatic 63% surge due to $100 million in government funding, the article highlights a critical concern: the company's annual burn rate of $80+ million means the grant only extends its lifespan by approximately 15 months, suggesting the funding is insufficient for long-term sustainability.

Expected to receive $100 million in federal funding, providing strategic support and validation for the emerging quantum computing company. Stock climbed 24.6%.

Receiving $100 million in federal funding with government equity stake; shares surged 14.58% in pre-market trading

Stock has declined 71% from peak, faces stiff competition, remains deeply unprofitable with lumpy revenue, and is overvalued at 126x 2027 sales. Author predicts stagnation or further decline over next 12 months.

While Rigetti shows impressive projected revenue growth (14x increase by 2028) and recent stock gains of 70%, the company remains unprofitable, is richly valued at 28x 2028 sales, and still needs to prove it can scale its business and compete with newer rivals like IonQ.

The company faces severe financial challenges with minimal revenue ($7.1M in 2025), massive operating losses ($216M), an unjustified P/S multiple of 607, structural cash burn of ~$100M annually, and insider selling near peak valuations. The article explicitly warns against buying the dip, characterizing the stock as a 'speculative falling knife.'

Company exceeded revenue expectations by 10.86%, launched advanced 108-qubit quantum computing system, announced significant $100 million U.K. investment, and maintains bullish analyst consensus with $34.86 average price target. Stock trading activity was positive on the news.

While the company beat revenue expectations and announced a significant product milestone (Cepheus-1-108Q in general availability), the stock declined 1.95% in after-hours trading. The company also reported a substantial non-GAAP net loss of $14.7 million for the quarter, indicating ongoing profitability challenges despite revenue growth.

Failed to advance in DARPA's QBI evaluation, declining year-over-year revenues, significantly behind competitors like IonQ in growth (IonQ: $61.9M revenue vs Rigetti: $1.9M), and using the same technology as better-funded competitors, making success unlikely.

Despite innovative quantum computing technology and forecasted revenue growth, the company faces severe financial headwinds including 34% revenue decline in 2025, $216 million operating loss, negative free cash flow, and extremely elevated valuation metrics (P/S ratio >730). The article explicitly recommends limiting to speculative positions or avoiding the stock entirely until financial conditions improve significantly.

Highest P/S ratio at 870, unprofitable, dependent on dilutive financing, and lacks competitive moat against established players entering the quantum space.

Despite operating in a promising industry, Rigetti shows poor fundamentals with declining revenue, massive operating losses relative to sales, and no clear path to profitability. The stock has lost 19% YTD and faces potential equity dilution when cash reserves deplete.

Rigetti is mentioned only in a comparative article title but receives no substantive discussion in the main article content.

Secured partnership with HPE and Pittsburgh Supercomputing Center backed by $5M NSF grant to build quantum computing testbed. This represents validation and funding support for commercializing quantum-enabled systems.

Secured $100 million funding award from U.S. Department of Commerce under the CHIPS Act to advance superconducting quantum computing R&D, indicating strong government support and resources for scaling quantum technology.

High customer concentration risk with one customer accounting for 64% of Q2 revenues, operating expenses rose 48% YoY against small revenue base, and R&D expenses increased 53%. Revenue profile remains tied to system delivery timing rather than recurring usage, and path to quantum advantage requires simultaneous progress across multiple technical challenges.

Mentioned only in comparison context without substantive analysis. The article references a comparison article but provides no direct sentiment indicators about the company itself.

Significant insider selling ($63M combined across three companies), weak insider ownership, no insider buying activity, unprofitable with high forward sales multiples relative to revenue, and high market cap ($5B+) despite limited commercialization progress.

Received $100 million investment from the Department of Commerce, supporting strategic tech development.

Stock up 7.40% following announcement of $100 million CHIPS Act funding, similar to other quantum computing companies receiving government support.

Revenue heavily concentrated with top two customers accounting for 80% of Q2 2026 revenues. Operating expenses rose 48% YoY with R&D up 53%, while revenue base remains small. Revenue profile dependent on system delivery timing rather than recurring commercial usage.

Mentioned as an emerging leader in quantum computing stocks that has surged 480-1,710% over two years, but no specific analysis or opinion is provided about the company itself.

Mentioned as a pure-play quantum company developing quantum machines and cloud services, included as one of multiple approaches to quantum computing without specific sentiment.

Mentioned as a volatile quantum stock alternative, but not recommended. No specific analysis or developments provided.

Rigetti is a competing quantum computing pure-play startup with its own unique technological approach. It represents competitive pressure in the quantum computing space alongside IonQ.

Rigetti is mentioned as a pure-play quantum firm experiencing a second major decline in 2026 alongside D-Wave. While facing competitive pressures from IQM's entry, the broader industry expansion may create opportunities for differentiation and innovation.

Stock is overvalued with a $5.6B market cap on only $7M in shrinking revenue (down 34% YoY). Significant share dilution from ATM program (~$100M raised) and government equity stakes pose downside risks. Stretched valuation with falling sales creates vulnerability to a sharp pullback if quantum hype fades.

Mentioned as a competitor in the quantum computing race with no specific commentary; subject to the same cash runway and dilution risk concerns mentioned for all quantum stocks.

Despite 65% stock appreciation, 2025 revenue declined year-over-year, making future contract wins critical. Trading at even higher sales multiples than D-Wave while showing revenue contraction presents significant valuation risk.

While Rigetti has smaller absolute sales than competitors, it showed notable YoY improvement. However, the article provides limited detail on its competitive positioning relative to D-Wave and IonQ.

While technology is advancing, revenue base is too thin ($4.4M in Q1) to justify current valuation with confidence. Stock is down 19% YTD and market cap implies commercial traction not yet demonstrated. Analyst is watching but not buying.

Rigetti accepted the federal funding deal, gaining government alignment and validation as part of the funded quantum sector, which may provide competitive advantages through federal contracts and infrastructure support.